Health Care

HealthAlliance Hospital has tapped a longtime hospital leader with experience in integrating community hospitals into larger medical centers as its next president and CEO.

Worcester-based UMass Memorial Health Care is partnering with a Minneapolis IT company to integrate patients' end-of-life directives into its electronic medical records system, a measure that's expected to reduce costs.

HealthAlliance Hospital is planning to lay off the equivalent of 6.5 full-time nursing and support staff positions at its Burbank Campus in Fitchburg, according to hospital officials.

UMass Memorial Health Care is navigating in turbulent times, but how long will they last for Central Massachusetts' largest health care system, and the region's largest employer?

The law of supply and demand is fundamental to any business model, but success depends on the ability to scale up operations to meet the demand.

Many of the helpful features envisioned when the state set out to build the Rolls-Royce of health insurance exchanges may have to be set aside for now, according to the Patrick administration, which is tempering expectations in advance of the scheduled re-launch of its exchange site this fall.

Construction of a new wing at Milford Regional Medical Center is underway, and while the hospital's new emergency department and intensive care units will house state-of-the-art technology and boast more square footage, the availability of more private rooms may be even more attractive to prospective patients. According to hospital administrators, new construction projects at Massachusetts hospitals must feature only single-patient rooms. That measure is designed to decrease the risk of contagion between patients and increase patient privacy, which has become increasingly important under state and federal laws governing medical privacy.

HealthAlliance Hospital of Leominster has laid off four employees, and executives are evaluating the need to cut for more, according to Interim President Michael Cofone.

Three months after being denied approval by the U.S. Food and Drug Administration, Cambridge-based Genzyme has won approval of its multiple sclerosis treatment in Brazil.

Ninety-seven days. That's the amount of time between the day Governor Patrick and President Obama praised the...